pharma · Pain · Hyponatremia · CPIX
Cumberland Pharmaceuticals
CUMBERLAND PHARMACEUTICALS INC
Cumberland Pharmaceuticals clinical programs — 19 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1600 W End Ave, #1300, Nashville, Tennessee 37203, US
- Founded
- 1999
- Employees
- 128
- Programs
- 53
- Drugs
- 26
- Patents
- 34
Cumberland Pharmaceuticals projects
19 ClinicalTrials.gov programs sponsored by Cumberland Pharmaceuticals.
Cumberland Pharmaceuticals has 19 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
90 grams of Crystalline Lactulose
CUMBERLAND PHARMACEUTICALS INC
Colonoscopy Preparation
1 trial -
Atorvastatin injection
CUMBERLAND PHARMACEUTICALS INC
Hypercholesterolemia
1 trial -
Crystalline Lactulose
CUMBERLAND PHARMACEUTICALS INC
Colonoscopy
1 trial -
Full dose preparation
CUMBERLAND PHARMACEUTICALS INC
Colonoscopy Preparation
1 trial -
Ifetroban
CUMBERLAND PHARMACEUTICALS INC
Portal Hypertension
1 trial -
Ifetroban
CUMBERLAND PHARMACEUTICALS INC
Duchenne Muscular Dystrophy Cardiomyopathy
1 trial -
Ifetroban Injection
CUMBERLAND PHARMACEUTICALS INC
Hepatorenal Syndrome
1 trial -
Ifetroban Oral Capsule
CUMBERLAND PHARMACEUTICALS INC
Asthma, Aspirin-Induced
1 trial -
Ifetroban Sodium
CUMBERLAND PHARMACEUTICALS INC
Cardiovascular Diseases
1 trial -
Ifetroban Sodium
CUMBERLAND PHARMACEUTICALS INC
Malignant Solid Tumor
1 trial -
Ifetroban Sodium
CUMBERLAND PHARMACEUTICALS INC
Idiopathic Pulmonary Fibrosis
1 trial -
Ifetroban, Oral Capsule
CUMBERLAND PHARMACEUTICALS INC
Aspirin Exacerbated Respiratory Disease (AERD)
1 trial -
N-Acetylcysteine (NAC)
CUMBERLAND PHARMACEUTICALS INC
Radiocontrast Nephropathy
1 trial -
Oral Ifetroban
CUMBERLAND PHARMACEUTICALS INC
Scleroderma, Diffuse
1 trial -
Telavancin
CUMBERLAND PHARMACEUTICALS INC
Gram-Positive Bacterial Infections
2 trials -
Telavancin
CUMBERLAND PHARMACEUTICALS INC
Infections, Gram-Positive Bacterial
2 trials -
conivaptan
CUMBERLAND PHARMACEUTICALS INC
Liver Cirrhosis
1 trial -
conivaptan
CUMBERLAND PHARMACEUTICALS INC
Chronic Heart Failure
1 trial -
ranibizumab
CUMBERLAND PHARMACEUTICALS INC
Retinal Vein Occlusion
1 trial
Frequently asked questions
How many clinical projects does Cumberland Pharmaceuticals have?
19 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.